Australië - Engels - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - sildenafil citrate -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - sildenafil citrate, quantity: 140.48 mg (equivalent: sildenafil, qty 100 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; hyprolose; calcium hydrogen phosphate dihydrate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; indigo carmine aluminium lake - treatment of erectile dysfunction in adult males. it is not indicated for use by women.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - sildenafil citrate -

Israël - Engels - Ministry of Health

abic marketing ltd, israel - sildenafil as citrate - film coated tablets - sildenafil as citrate 100 mg - sildenafil - sildenafil teva ® 100 mg fc tablets is indicated for the treatment of erectile dysfunction.

Israël - Engels - Ministry of Health

abic marketing ltd, israel - sildenafil as citrate - film coated tablets - sildenafil as citrate 25 mg - sildenafil - sildenafil teva ® 25 mg fc tablets is indicated for the treatment of erectile dysfunction.

Israël - Engels - Ministry of Health

abic marketing ltd, israel - sildenafil as citrate - film coated tablets - sildenafil as citrate 50 mg - sildenafil - sildenafil teva® 50 mg fc tablets is indicated for the treatment of erectile dysfunction.

Verenigde Staten - Engels - NLM (National Library of Medicine)

vensun pharmaceuticals, inc. - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (who group i) in adults to improve exercise ability and delay clinical worsening. the delay in clinical worsening was demonstrated when sildenafil tablets were added to background epoprostenol therapy [see clinical studies (14)]. studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with new york heart association (nyha) functional class ii-iii symptoms and idiopathic etiology (71%) or associated with connective tissue disease (ctd) (25%). limitation of use : adding sildenafil to bosentan therapy does not result in any beneficial effect on exercise capacity [see clinical studies (14)]. sildenafil tablets are contraindicated in patients with: -   concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions (5.2)]. -   concomitant use of riociguat, a guanylate cyclase stimulator.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - sildenafil citrate -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - sildenafil citrate -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - sildenafil citrate -